Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 229.21B | 229.21B | 195.94B | 186.79B | 162.44B | 150.37B |
Gross Profit | 77.40B | 77.40B | 56.48B | 54.44B | 51.13B | 45.05B |
EBITDA | 24.77B | 26.52B | 13.34B | 16.40B | 15.72B | 15.63B |
Net Income | 13.32B | 13.32B | 2.70B | 7.39B | 8.91B | 7.15B |
Balance Sheet | ||||||
Total Assets | 262.17B | 262.17B | 228.43B | 212.08B | 196.84B | 184.51B |
Cash, Cash Equivalents and Short-Term Investments | 35.59B | 35.59B | 18.33B | 14.97B | 16.15B | 10.88B |
Total Debt | 60.71B | 60.71B | 46.73B | 44.78B | 43.55B | 43.70B |
Total Liabilities | 115.78B | 115.78B | 97.55B | 90.13B | 86.55B | 83.17B |
Stockholders Equity | 144.20B | 144.20B | 129.06B | 120.21B | 108.61B | 99.97B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 7.62B | 2.33B | -589.00M | 3.52B | 6.78B |
Operating Cash Flow | 0.00 | 18.92B | 10.01B | 5.82B | 11.57B | 13.73B |
Investing Cash Flow | 0.00 | -9.13B | -6.82B | -3.28B | -7.26B | -4.28B |
Financing Cash Flow | 0.00 | 6.88B | -453.00M | -2.04B | -2.36B | -7.86B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | 85.47B | 10.72 | 9.37% | 2.52% | 1.84% | 10.75% | |
80 Outperform | ¥157.86B | 12.81 | ― | 2.48% | 14.21% | 119.74% | |
77 Outperform | 163.73B | 12.62 | 6.72% | 3.59% | 5.52% | -5.40% | |
74 Outperform | 117.57B | 11.71 | 8.02% | 3.83% | 4.86% | 11.72% | |
73 Outperform | 122.48B | 17.57 | 6.02% | 2.55% | 5.87% | 0.90% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |
Takasago International Corporation reported its financial results for the first quarter of FY2025, highlighting a 4.5% increase in sales compared to FY2024, driven by growth in Asian and European markets. However, the company experienced a decrease in operating and net profits, attributed to unfavorable exchange rate fluctuations and a decline in exports of fine chemicals in Japan, impacting its overall profitability.
Takasago International Corporation reported its consolidated financial results for the three months ending June 30, 2025, showing a 4.5% increase in net sales compared to the previous year. However, the company experienced a decline in operating and ordinary profits by 1.7% and 28.3% respectively, indicating potential challenges in maintaining profitability. The company also announced a stock split scheduled for October 1, 2025, which may affect dividend comparisons before and after the split.
Takasago International Corporation has acquired land in Kamakura City, Japan, to construct a new R&D center as part of its Vision 2040 strategy. This acquisition aims to enhance the company’s R&D capabilities, aligning with its mission to innovate and support sustainable growth, though the immediate financial impact is expected to be minor.
Takasago International Corporation announced revisions to its financial briefing for the fiscal year ended March 2025, correcting inaccuracies in reported year-on-year sales and operating profit figures. This amendment aims to maintain transparency and accuracy in the company’s financial disclosures, which is crucial for stakeholders’ trust and the company’s reputation in the competitive flavor and fragrance industry.
Takasago International Corporation reported a significant increase in its financial performance for the fiscal year ended March 31, 2025, with net sales growing by 17% and operating profit surging by 562.4% compared to the previous year. The company also announced a substantial increase in dividends, reflecting its strong financial position and commitment to returning value to shareholders.
Takasago International Corporation has announced significant changes in its Board of Directors, Audit & Supervisory Board Members, and Corporate Officers, effective June 25, 2025. These changes are part of the company’s strategic efforts to enhance its leadership structure and strengthen its global operations, potentially impacting its market positioning and stakeholder relations.
Takasago International Corporation has reported a foreign exchange loss of 566 million yen as non-operating expenses for the fiscal year ending March 31, 2025. This loss, primarily due to the revaluation of foreign currency-denominated assets, has been accounted for in the company’s consolidated financial statements, potentially impacting its financial performance and signaling challenges in managing currency risks.
Takasago International Corporation reported a significant financial performance for the fiscal year ending March 31, 2025, with a 17.0% increase in consolidated net sales to ¥229,207 million. The company experienced substantial growth across its segments, particularly in the Fine Chemicals segment, which saw an 84.0% increase in sales. Operating profit surged by 562.4%, and net income attributable to shareholders rose by 393.8%. These results reflect the company’s successful implementation of its mid-term management plan ‘New Global Plan-2’ and its strategic focus on optimizing product mix and increasing inter-segment sales.